Calidi Biotherapeutics, Inc. Common Stock — Cash Flow (NYSE:CLDI) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities —98.05 K-26.98 M-19.69 M-21.29 M -17.75 M Cash from investing activities —187.69 M-478 K-16 K-170 K -144 K Cash from financing activities —-188.75 M29.04 M27.36 M17.46 M 16.81 M Free cash flow —98.05 K-26.98 M-19.69 M-21.41 M -17.84 M

News

Upcoming Stock Splits This Week (July 27 to July 31) – Stay Invested - TipRanks.com

Calidi Biotherapeutics closes $6M public offering

Calidi Biotherapeutics (CLDI) Stock Plunges 35% After Hours — Here's Why - Calidi Biotherapeutics (AMEX:CLDI)

Calidi Biotherapeutics announces underwritten public offering

Beyond Meat appoints Tony Kalajian as chief accounting officer

H.C. Wainwright reiterates Buy rating on Connect Biopharma stock at $7 target

Calidi Biotherapeutics closes $6.9 million public offering

Calidi Biotherapeutics finalizes separation agreement with Dr. Boris Minev

Upcoming Stock Splits This Week (August 4 to August 8) – Stay Invested - TipRanks.com

FDA grants fast track designation to Calidi’s CLD-201 for sarcoma

Calidi Biotherapeutics secures $4.6 million through warrant exercise

Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories! - TipRanks.com